Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...
EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency
EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency: Brussels, Belgium Monday, February 2, 2026, 15:00 Hrs [IST] UCB, a global b ...
The £1.1m Rosetta Stone study hopes to make a breakthrough by comparing both conditions.
ABP News on MSNOpinion
Does your plate have a key to clock off cancer cells? Here's what research suggests
(By Dr. Mandeep Singh Malhotra) Cancer still remains a prominent cause of mortality across the globe. Despite recent ...
Morning Overview on MSN
Simple blood test may spot Parkinson’s decades before symptoms
For decades, Parkinson’s disease has been diagnosed only after unmistakable symptoms such as tremor, stiffness, and slowed ...
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Peripheral neuropathy has become one of the fastest-growing quality-of-life challenges in 2026, especially among people living with diabetes, ...
Once a subject of sci?fi fantasy, the idea of slowing biological aging is rapidly entering the mainstream. Swiss longevity pioneer Paremina is at the forefront of this shift with Ageless Cell, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results